Biogen Idec Inc. (NASDAQ: BIIB) will continue on its present course as an independent company after BIIB's Board of Directors completed a review of strategic alternatives to maximize shareholder value:
BIIB recently traded at $56.60 in after market trading, below its close of $75.88. BIIB December straddle went out at $6.35. BIIB January option implied volatility of 55 is above its 26-week average of 37 according to Track Data, suggesting options traders expected movement.
Daily Options Update is provided by Stock Specialist Paul Foster of theflyonthewall.com.
Tax Reform in This Election Year: It's Not Likely
Which Credit Card Rewards Does the IRS Care About?

